Mangalam Drugs And Organics Limited has informed the Exchange regarding Appointment of Mr Mr. Ajay Avinash Samant as Chief Financial Officer of the company w.e.f. April 11, 2025.
MANGALAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.2 pts less than Nifty Microcap 250 and 2.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Mangalam Drugs And Organics Limited has announced the appointment of Mr. Ajay Avinash Samant as the new Chief Financial Officer of the company. The appointment is effective from April 11, 2025. Mr. Samant will take on the key finance leadership role at the company. No additional details about his prior experience or background were mentioned in the filing.
This is a routine key managerial personnel (KMP) change. For shareholders, this indicates continuity in financial oversight, though investors may want to watch for any further updates on the CFO's background or strategic direction in upcoming quarters.